Global Geriatric Medicines Market Size, Share, Forecast Report, 2020-2027

The global Geriatric Medicines market garnered revenue around USD 671.6 Billion in 2019 and projected to reach USD 1141.7 Billion in 2027, with at a compound annual growth rate (CAGR) 6.8% throughout the estimate period from 2020 to 2027.

Geriatric medicines are a specialty branch of medical science that provides diagnosis and treatment options for the elderly. Most geriatrics are unable to take their medication properly at a scheduled time, due to complex medical and psychological problems. The geriatric population requires special care and attention for the speedy recovery of disease or disorder. The global geriatric medicines market is expanding at a significant pace due to increasing government support toward old people for their health, safety, and nursing care. Developed nations already have quality geriatric care management systems in place and developing nations are making high investments in geriatric care.

North America dominated the global geriatric medicine market in 2019 and the trend is anticipated to continue during the forecast period. Highly structured health care industry, concentration of global market players, and high awareness about latest therapeutic advancements in the region are expected to drive the market in North America.

Asia Pacific is likely to be a highly lucrative market for retinal disorders and it is expected to expand at a high CAGR during the forecast period

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Geriatric Medicines market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Geriatric Medicines market growth.

The global Geriatric Medicines market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

the global market include Pfizer, Inc., Merck & Co., Inc., AstraZeneca, Bristol-Myers Squibb Company, Novartis AG, Sanofi S.A., GlaxoSmithKline plc Eli Lilly and Company, Abbott Laboratories, and Boehringer Ingelheim GmbH among others

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

• Global Geriatric medicine Market, by Therapeutic Category
  • Analgesic
  • Antihypertensive
  • Statins
  • Antidiabetic
  • Proton Pump Inhibitor
  • Anticoagulant
  • Antipsychotic and Antidepressant
  • Others
• Global Geriatric medicine Market, by Condition
  • Cardiovascular
  • Arthritis
  • Diabetes
  • Neurological
  • Cancer
  • Osteoporosis
  • Respiratory
  • Others
• Global Geriatric medicine Market, by Condition
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA